The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma

Oncotarget
Ryo AshidaKen Yamaguchi

Abstract

Project HOPE (High-tech Omics-based Patient Evaluation) began in 2014 using integrated gene expression profiling (GEP) of cancer tissues as well as diathesis of each patient who underwent an operation at our institution. The aim of this study was to clarify the association between the expression of cytochrome P450s (CYP) genes and recurrence of hepatocellular carcinoma (HCC). The present study included 92 patients. Genes with aberrant expression were selected based on a ≥10-fold difference in the expression between tumor and non-tumor tissues. The GEP analysis showed that the down-regulated genes in tumor tissue were CYP3A4 in 56 patients (61%), CYP2C8 in 44 patients (48%), CYP2C19 in 30 patients (33%), CYP2D6 in 11 patients (12%), CYP3A5 in 7 patients (8%) and CYP1B1 in 2 patients (2%). There was no patients with down-regulation of the CYP17A1 gene. A multivariate analysis revealed that the presence of microscopic portal invasion (hazard ratio [HR] 2.57, 95% confidence interval [CI] 1.30-5.05 P = 0.006), the presence of intrahepatic-metastasis (HR 3.09 95% CI 1.52-6.29 P = 0.002) and down-regulation of the CYP2C19 gene (HR 3.69 95% CI 1.83-7.46 P < 0.001) were independent predictors for the recurrence-free survival (RFS). The ...Continue Reading

References

Jun 1, 1994·Journal of the National Cancer Institute·D G AltmanM Schumacher
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Sep 12, 2002·Clinical Pharmacokinetics·Zeruesenay DestaDavid A Flockhart
Oct 24, 2003·Naunyn-Schmiedeberg's Archives of Pharmacology·Magnus Ingelman-Sundberg
Jul 9, 2004·International Journal of Cancer. Journal International Du Cancer·Jenny C HoSheung Tat Fan
Jul 29, 2005·Journal of Gastroenterology and Hepatology·Junko MochizukiAkihiro Ohnishi
Mar 22, 2006·Oncogene·C Rodriguez-Antona, M Ingelman-Sundberg
Jun 23, 2012·Molecular Pharmacology·Shu-Yun ZhangJoyce A Goldstein
May 8, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ke ZhangYi Mu
Nov 5, 2014·Nature Genetics·Yasushi TotokiTatsuhiro Shibata
Jan 13, 2015·World Journal of Gastroenterology : WJG·Yusuke YamamotoEigo Otsuji
Oct 24, 2015·Nature Reviews. Cancer·Jens U MarquardtSnorri S Thorgeirsson
Oct 19, 2016·Journal of Hepatology·Kornelius SchulzeAugusto Villanueva
Jul 22, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xiaojing TangShuqing Chen
Mar 25, 2017·Journal of Hepatology·Paola BertuccioEva Negri
Aug 26, 2017·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Kathryn Elisa BurnsNuala Ann Helsby
Nov 8, 2017·Cancer Genomics & Proteomics·Ryo AshidaKen Yamaguchi
Feb 27, 2018·Cancer Medicine·Xiangkun WangTao Peng

❮ Previous
Next ❯

Software Mentioned

Excel
SPSS
GeneSpring GX

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.